UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of February 2025
Commission File Number: 001-41411
Haleon plc
(Translation of registrant’s name into English)
Building 5, First Floor, The Heights,
Weybridge, Surrey, KT13 0NY
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
Form 20-F ☒ | Form 40-F ☐ |
EXHIBIT INDEX
| Exhibit Number | Description |
| 99.1 | 03 February 2025 – “Total Voting Rights” |
99.1
Haleon plc: Total Voting Rights and Capital
3 February 2025: As at 31 January 2025 the total number of shares issued by Haleon plc ("Haleon" or the "Company") is 9,083,725,919 ordinary shares of £0.01 each, of which 29,580,205 are held as treasury shares.
Therefore, the number of ordinary shares with voting rights is 9,054,145,714 and this figure should be used by shareholders (and others with notification obligations) as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.
Notifiable interests in Haleon may be sent to: company.secretary@haleon.com
Amanda Mellor
Company Secretary
About Haleon
Haleon (LSE / NYSE: HLN) is a global leader in consumer health, with a purpose to deliver better everyday health with humanity. Haleon's product portfolio spans five major categories - Oral Health, Pain Relief, Respiratory Health, Digestive Health and Other, and Vitamins, Minerals and Supplements (VMS). Its long-standing brands - such as Advil, Sensodyne, Panadol, Voltaren, Theraflu, Otrivin, Polident, parodontax and Centrum - are built on trusted science, innovation and deep human understanding.
For more information, please visit www.haleon.com.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
HALEON PLC (Registrant) | |||
| Date: February 03, 2025 | By: | /s/ Amanda Mellor | |
| Name: | Amanda Mellor | ||
| Title: | Company Secretary | ||